Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Decreasing and stabilising trends of antimicrobial consumption and resistance in Escherichia coli and Klebsiella pneumoniae in segmented regression analysis, European Union/European Economic Area, 2001 to 2018.

Peñalva G, Högberg LD, Weist K, Vlahović-Palčevski V, Heuer O, Monnet DL, Esac-Net Study Group, Ears-Net Study Group.

Euro Surveill. 2019 Nov;24(46). doi: 10.2807/1560-7917.ES.2019.24.46.1900656.

2.

The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance.

Vandenbroucke-Grauls CMJE, Kahlmeter G, Kluytmans J, Kluytmans-van den Bergh M, Monnet DL, Simonsen GS, Skov RL, Wolff Sönksen U, Voss A.

BMJ Glob Health. 2019 Aug 21;4(4):e001838. doi: 10.1136/bmjgh-2019-001838. eCollection 2019. No abstract available.

3.

Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.

Jarlier V, Diaz Högberg L, Heuer OE, Campos J, Eckmanns T, Giske CG, Grundmann H, Johnson AP, Kahlmeter G, Monen J, Pantosti A, Rossolini GM, van de Sande-Bruinsma N, Vatopoulos A, Żabicka D, Žemličková H, Monnet DL, Simonsen GS; Ears-Net Participants.

Euro Surveill. 2019 Aug;24(33). doi: 10.2807/1560-7917.ES.2019.24.33.1800538.

4.

Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries.

D'Atri F, Arthur J, Blix HS, Hicks LA, Plachouras D, Monnet DL; The European Survey On Transatlantic Task Force On Antimicrobial Resistance Tatfar Action Group.

Euro Surveill. 2019 Jul;24(28). doi: 10.2807/1560-7917.ES.2019.24.28.1800339.

5.

Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018.

Brolund A, Lagerqvist N, Byfors S, Struelens MJ, Monnet DL, Albiger B, Kohlenberg A; European Antimicrobial Resistance Genes Surveillance Network EURGen-Net Capacity Survey Group.

Euro Surveill. 2019 Feb;24(9). doi: 10.2807/1560-7917.ES.2019.24.9.1900123.

6.

Attributable deaths caused by infections with antibiotic-resistant bacteria in France - Authors' reply.

Cassini A, Plachouras D, Monnet DL.

Lancet Infect Dis. 2019 Feb;19(2):129-130. doi: 10.1016/S1473-3099(19)30004-0. Epub 2019 Jan 30. No abstract available.

PMID:
30722997
7.

Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.

Plachouras D, Kärki T, Hansen S, Hopkins S, Lyytikäinen O, Moro ML, Reilly J, Zarb P, Zingg W, Kinross P, Weist K, Monnet DL, Suetens C; The Point Prevalence Survey Study Group.

Euro Surveill. 2018 Nov;23(46). doi: 10.2807/1560-7917.ES.23.46.1800393. Erratum in: Euro Surveill. 2018 Nov;23(47):.

8.

Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017.

Ricchizzi E, Latour K, Kärki T, Buttazzi R, Jans B, Moro ML, Nakitanda OA, Plachouras D, Monnet DL, Suetens C, Kinross P; The Halt Study Group.

Euro Surveill. 2018 Nov;23(46). doi: 10.2807/1560-7917.ES.2018.23.46.1800394.

9.

Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017.

Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, Jans B, Hopkins S, Hansen S, Lyytikäinen O, Reilly J, Deptula A, Zingg W, Plachouras D, Monnet DL; The Healthcare-Associated Infections Prevalence Study Group.

Euro Surveill. 2018 Nov;23(46). doi: 10.2807/1560-7917.ES.2018.23.46.1800516. Erratum in: Euro Surveill. 2018 Nov;23(47):.

10.

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, Ouakrim DA, Oliveira TC, Struelens MJ, Suetens C, Monnet DL; Burden of AMR Collaborative Group.

Lancet Infect Dis. 2019 Jan;19(1):56-66. doi: 10.1016/S1473-3099(18)30605-4. Epub 2018 Nov 5.

11.

Do medical students feel prepared to prescribe antibiotics responsibly? Results from a cross-sectional survey in 29 European countries.

Dyar OJ, Nathwani D, Monnet DL, Gyssens IC, Stålsby Lundborg C, Pulcini C; ESGAP Student-PREPARE Working Group.

J Antimicrob Chemother. 2018 Aug 1;73(8):2236-2242. doi: 10.1093/jac/dky150.

PMID:
29746647
12.

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017.

Kohlenberg A, Struelens MJ, Monnet DL, Plachouras D; The Candida Auris Survey Collaborative Group.

Euro Surveill. 2018 Mar;23(13). doi: 10.2807/1560-7917.ES.2018.23.13.18-00136.

13.

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group.

Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.

PMID:
29276051
14.

Livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) among human MRSA isolates, European Union/European Economic Area countries, 2013.

Kinross P, Petersen A, Skov R, Van Hauwermeiren E, Pantosti A, Laurent F, Voss A, Kluytmans J, Struelens MJ, Heuer O, Monnet DL; The European Human LA-Mrsa Study Group.

Euro Surveill. 2017 Nov;22(44). doi: 10.2807/1560-7917.ES.2017.22.44.16-00696.

15.

Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.

Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT, Cantón R, Carmeli Y, Friedrich AW, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Nordmann P, Poirel L, Rossolini GM, Seifert H, Vatopoulos A, Walsh T, Woodford N, Monnet DL; European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group.

Lancet Infect Dis. 2017 Feb;17(2):153-163. doi: 10.1016/S1473-3099(16)30257-2. Epub 2016 Nov 18.

PMID:
27866944
16.

Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.

Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, Haller S, Harder T, Klingeberg A, Sixtensson M, Velasco E, Weiß B, Kramarz P, Monnet DL, Kretzschmar ME, Suetens C.

PLoS Med. 2016 Oct 18;13(10):e1002150. doi: 10.1371/journal.pmed.1002150. eCollection 2016 Oct.

17.

A Concise Set of Structure and Process Indicators to Assess and Compare Antimicrobial Stewardship Programs Among EU and US Hospitals: Results From a Multinational Expert Panel.

Pollack LA, Plachouras D, Sinkowitz-Cochran R, Gruhler H, Monnet DL, Weber JT; Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) Expert Panel on Stewardship Structure and Process Indicators.

Infect Control Hosp Epidemiol. 2016 Oct;37(10):1201-11. doi: 10.1017/ice.2016.115. Epub 2016 Jul 15.

18.

Comment on: A systematic review of the public's knowledge and beliefs about antibiotic resistance.

Monnet DL, Safrany N, Heine N, Price C.

J Antimicrob Chemother. 2016 Aug;71(8):2364-5. doi: 10.1093/jac/dkw141. Epub 2016 May 26. No abstract available.

19.

Contamination during production of heater-cooler units by Mycobacterium chimaera potential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016.

Haller S, Höller C, Jacobshagen A, Hamouda O, Abu Sin M, Monnet DL, Plachouras D, Eckmanns T.

Euro Surveill. 2016 Apr 28;21(17). doi: 10.2807/1560-7917.ES.2016.21.17.30215.

20.

Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds.

Skov RL, Monnet DL.

Euro Surveill. 2016;21(9):30155. doi: 10.2807/1560-7917.ES.2016.21.9.30155. No abstract available.

21.

Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.

Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL; European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group.

Euro Surveill. 2015;20(45). doi: 10.2807/1560-7917.ES.2015.20.45.30062. Erratum in: Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30089. Euro Surveill. 2016 Sep 22;21(38):.

22.

Severe Ebola virus infection complicated by gram-negative septicemia.

Plachouras D, Monnet DL, Catchpole M.

N Engl J Med. 2015 Apr 2;372(14):1376-7. doi: 10.1056/NEJMc1500455. No abstract available.

PMID:
25830440
23.

Antibiotic use worldwide.

Högberg LD, Muller A, Zorzet A, Monnet DL, Cars O.

Lancet Infect Dis. 2014 Dec;14(12):1179-80. doi: 10.1016/S1473-3099(14)70987-9. Epub 2014 Nov 17. No abstract available.

PMID:
25455983
24.

European Antibiotic Awareness Day: a five-year perspective of Europe-wide actions to promote prudent use of antibiotics.

Earnshaw S, Mancarella G, Mendez A, Todorova B, Magiorakos AP, Possenti E, Stryk M, Gilbro S, Goossens H, Albiger B, Monnet DL; European Antibiotic Awareness Day Technical Advisory Committee; European Antibiotic Awareness Day Collaborative Group.

Euro Surveill. 2014 Oct 16;19(41). pii: 20928.

25.

Antimicrobial resistance surveillance in Europe: regional pooling of national data from a small number of sites can be misleading.

Högberg LD, Magiorakos AP, Heuer OE, Monnet DL.

Diagn Microbiol Infect Dis. 2014 Sep;80(1):90. doi: 10.1016/j.diagmicrobio.2014.03.015. Epub 2014 Mar 25. No abstract available.

26.

Drug-resistant Salmonella enterica serotype Kentucky in Europe.

Westrell T, Monnet DL, Gossner C, Heuer O, Takkinen J.

Lancet Infect Dis. 2014 Apr;14(4):270-1. doi: 10.1016/S1473-3099(14)70703-0. No abstract available.

PMID:
24670624
27.

The role and utilisation of public health evaluations in Europe: a case study of national hand hygiene campaigns.

Latham JR, Magiorakos AP, Monnet DL, Alleaume S, Aspevall O, Blacky A, Borg M, Ciurus M; Spanish Hand Hygiene Campaign, Costa AC, Cunney R, Dolinšek M, Dumpis U, Erne S, Gudlaugsson O, Hedlova D, Heisbourg E, Holt J, Kerbo N, Sorknes NK, Lyytikäinen O, Maltezou HC, Michael S, Moro ML, Reichardt C, Stefkovicova M, Szilágyi E, Valinteliene R, Vatcheva-Dobrevska R, Viseur N, Voss A, Woodward S, Cordier L, Jansen A.

BMC Public Health. 2014 Feb 7;14:131. doi: 10.1186/1471-2458-14-131.

28.

Public health need versus sales of antibacterial agents active against multidrug-resistant bacteria: a historical perspective.

Monnet DL, Giesecke J.

J Antimicrob Chemother. 2014 Apr;69(4):1151-3. doi: 10.1093/jac/dkt478. Epub 2013 Dec 16. No abstract available.

29.

Global collaboration to encourage prudent antibiotic use.

Earnshaw S, Mendez A, Monnet DL, Hicks L, Cruickshank M, Weekes L, Njoo H, Ross S.

Lancet Infect Dis. 2013 Dec;13(12):1003-4. doi: 10.1016/S1473-3099(13)70315-3. Epub 2013 Nov 17. No abstract available.

PMID:
24252477
30.

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013.

Glasner C, Albiger B, Buist G, Tambić Andrasević A, Canton R, Carmeli Y, Friedrich AW, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Nordmann P, Poirel L, Rossolini GM, Seifert H, Vatopoulos A, Walsh T, Woodford N, Donker T, Monnet DL, Grundmann H; European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group.

Euro Surveill. 2013 Jul 11;18(28). pii: 20525. Erratum in: Euro Surveill. 2013;18. pii: 20575. Euro Surveill. 2014;19(47): pii=20972.

31.

The rise of carbapenem resistance in Europe: just the tip of the iceberg?

Magiorakos AP, Suetens C, Monnet DL, Gagliotti C, Heuer OE; EARS-Net Coordination Group and EARS-Net participants.

Antimicrob Resist Infect Control. 2013 Feb 14;2(1):6. doi: 10.1186/2047-2994-2-6.

32.

The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.

Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, Goossens M, Vaerenberg S, Hopkins S, Catry B, Monnet D, Goossens H, Suetens C; National Contact Points for the ECDC pilot point prevalence survey; Hospital Contact Points for the ECDC pilot point prevalence survey.

Euro Surveill. 2012 Nov 15;17(46). pii: 20316.

33.

Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment.

Aldrin M, Raastad R, Tvete IF, Berild D, Frigessi A, Leegaard T, Monnet DL, Walberg M, Müller F.

Stat Med. 2013 Apr 15;32(8):1407-18. doi: 10.1002/sim.5636. Epub 2012 Oct 1.

PMID:
23027651
34.

Hand hygiene practices in healthcare: measure and improve.

Monnet DL, Sprenger M.

Euro Surveill. 2012 May 3;17(18). pii: 20166. No abstract available.

35.

Antibiotics obtained without a prescription in Europe.

Safrany N, Monnet DL.

Lancet Infect Dis. 2012 Mar;12(3):182-3. doi: 10.1016/S1473-3099(12)70017-8. No abstract available.

PMID:
22361429
36.

Surveillance status and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012.

Lenglet A, Herrador Z, Magiorakos AP, Leitmeyer K, Coulombier D; European Working Group on Mycoplasma pneumoniae surveillance.

Euro Surveill. 2012 Feb 2;17(5). pii: 20075.

37.

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL.

Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27.

38.

Raising awareness about prudent use of antibiotics: a necessity for the European Union.

Monnet DL.

Enferm Infecc Microbiol Clin. 2010 Nov;28 Suppl 4:1-3. doi: 10.1016/S0213-005X(10)70034-3. No abstract available.

PMID:
21458692
39.

Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.

Freire-Moran L, Aronsson B, Manz C, Gyssens IC, So AD, Monnet DL, Cars O; ECDC-EMA Working Group.

Drug Resist Updat. 2011 Apr;14(2):118-24. doi: 10.1016/j.drup.2011.02.003. Epub 2011 Mar 23. Review.

PMID:
21435939
40.

Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009.

Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gür D, Jarlier V, Kahlmeter G, Monen J, Monnet DL, Rossolini GM, Suetens C, Weist K, Heuer O; EARS-Net Participants (Disease Specific Contact Points for AMR).

Euro Surveill. 2011 Mar 17;16(11). pii: 19819. Erratum in: Euro Surveill. 2011;16(14):pii/19834.

41.

Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe.

van Cleef BA, Monnet DL, Voss A, Krziwanek K, Allerberger F, Struelens M, Zemlickova H, Skov RL, Vuopio-Varkila J, Cuny C, Friedrich AW, Spiliopoulou I, Pászti J, Hardardottir H, Rossney A, Pan A, Pantosti A, Borg M, Grundmann H, Mueller-Premru M, Olsson-Liljequist B, Widmer A, Harbarth S, Schweiger A, Unal S, Kluytmans JA.

Emerg Infect Dis. 2011 Mar;17(3):502-5. doi: 10.3201/eid1703.101036.

42.

New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe.

Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J; European NDM-1 Survey Participants.

Euro Surveill. 2010 Nov 18;15(46). pii: 19716.

43.

Clostridium difficile infection in Europe: a hospital-based survey.

Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ; ECDIS Study Group.

Lancet. 2011 Jan 1;377(9759):63-73. doi: 10.1016/S0140-6736(10)61266-4.

PMID:
21084111
44.
45.

Self-medication with antibiotics in Europe: a case for action.

Grigoryan L, Monnet DL, Haaijer-Ruskamp FM, Bonten MJ, Lundborg S, Verheij TJ.

Curr Drug Saf. 2010 Oct;5(4):329-32. Review.

PMID:
20615180
46.

Increase in pneumococcus macrolide resistance, USA.

Hicks LA, Monnet DL, Roberts RM.

Emerg Infect Dis. 2010 May;16(5):896-7. doi: 10.3201/eid1605.091424. No abstract available.

47.

Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance.

Jensen US, Muller A, Brandt CT, Frimodt-Møller N, Hammerum AM, Monnet DL; DANRES study group.

J Antimicrob Chemother. 2010 Jun;65(6):1286-91. doi: 10.1093/jac/dkq093. Epub 2010 Apr 2.

PMID:
20363806
48.

Antibiotic resistance in Europe: the challenges ahead.

ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme.

Euro Surveill. 2009 Nov 12;14(45). pii: 19405. No abstract available.

49.

Experience of European intensive care physicians with infections due to antibiotic-resistant bacteria, 2009.

Lepape A, Monnet DL; participating members, European Society of Intensive Care Medicine.

Euro Surveill. 2009 Nov 12;14(45). pii: 19393.

50.

European Antibiotic Awareness Day, 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries.

Earnshaw S, Monnet DL, Duncan B, O'Toole J, Ekdahl K, Goossens H; European Antibiotic Awareness Day Technical Advisory Committee; European Antibiotic Awareness Day Collaborative Group.

Euro Surveill. 2009 Jul 30;14(30):19280.

Supplemental Content

Loading ...
Support Center